MAOB and amyotrophic lateral sclerosis: The development of astrocyte-specific ligands, such as [11C](L)-deprenyl-D2, which enables the measurement of monoamine oxidase B (MAO-B) levels, has indeed served as a powerful tool to track astrocyte activation by positron emission tomography (PET) in ALS [50].